AACR Annual Meeting 2017: First Analyses of AACR Project GENIE Data Presented in Major Symposium
Members of the AACR Project GENIE consortium presented their first analyses of the data during the Pan-Cancer Genomic Analysis...
Category: Meetings
Members of the AACR Project GENIE consortium presented their first analyses of the data during the Pan-Cancer Genomic Analysis...
Two studies presented at the AACR Annual Meeting 2017 showed that tumors that have mutations in the proteins isocitrate...
On March 23, the U.S. Food and Drug Administration announced the first-ever approval of a treatment for patients with...
Finding a way to therapeutically target the so-called “undruggable” cancer proteins has long been a holy grail of researchers...
The Affordable Care Act, which was enacted in 2010 and recently survived an effort to dismantle it, was the...
Identifying ways to increase the proportion of patients with melanoma who have clinically meaningful and durable responses to immune...
Now that a plethora of clinical trials have established positive responses from immunotherapies—immune checkpoint inhibitors, in particular—in patients with...
Earlier this week, the U.S. Food and Drug Administration (FDA) approved the molecularly targeted therapeutic niraparib (Zejula) for the...
As part of a growing public affairs program, the American Association for Cancer Research is excited to once again...
A big career fair can be somewhat intimidating, so we asked some hiring experts for their advice on how...